1 | Acthar low dose (40 U) | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 49 49 |
2 | Administration of a low dose of desipramine | [1] Desipramine Desipramine | [2] D00812
D00812
,
D07791
| [2] SLC6A2 SLC6A2, SLC6A4 💬 | [2] Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 156 156 |
3 | Ambrisentan - low dose | [1] Ambrisentan Ambrisentan | [1] D07077
D07077
| [1] EDNRA EDNRA 💬 | [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 86 86 |
4 | AXO-AAV-GM2 Low Dose | - | - | - | - | [1] 19 19 |
5 | BI 655064 low dose | - | - | - | - | [1] 46 46 |
6 | BIIL 284 BS low dose | - | - | - | - | [1] 46 46 |
7 | BIIL 284 BS, low dose | - | - | - | - | [1] 299 299 |
8 | BIIL 284 BS, low dose, adult patients | - | - | - | - | [1] 299 299 |
9 | BIIL 284 BS, low dose, pediatric patients | - | - | - | - | [1] 299 299 |
10 | BIRB 796 BS, low dose | - | - | - | - | [1] 46 46 |
11 | BLI-1300 low dose | - | - | - | - | [1] 96 96 |
12 | Brazikumab low dose | [1] Brazikumab Brazikumab | [1] D10912
D10912
| [1] IL23A IL23A 💬 | [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [1] 96 96 |
13 | Clobazam Low Dose | [1] Clobazam Clobazam | [1] D01253
D01253
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [1] 144 144 |
14 | CVN424 Low Dose | - | - | - | - | [1] 6 6 |
15 | CVT-301 Low Dose | - | - | - | - | [1] 6 6 |
16 | Cyclosporin, low dose steroid | [1] Cyclosporine Cyclosporine | [1] D00184
D00184
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 | [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 222 222 |
17 | Elamipretide (low dose) | [1] Elamipretide Elamipretide | [1] D10925
D10925
| - | - | [1] 21 21 |
18 | EUR-1008 (APT-1008) Low Dose | - | - | - | - | [1] 298 298 |
19 | Fentanyl (Low Dose) | [1] Fentanyl Fentanyl | [2] D00320
D00320
,
D01399
| [1] OPRM1 OPRM1 💬 | [3] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 💬 | [1] 215 215 |
20 | Fentanyl (Low Dose) + Dexmedetomidine | [2] Dexmedetomidine Dexmedetomidine, Fentanyl | [4] D00320
D00320
,
D00514
,
D01205
,
D01399
| [4] ADRA2A ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 | [4] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | [1] 215 215 |
21 | HMPL-004 low dose | - | - | - | - | [1] 97 97 |
22 | IgPro20 (low dose) | - | - | - | - | [1] 14 14 |
23 | Iloprost low dose | [1] Iloprost Iloprost | [1] D02721
D02721
| [1] PTGIR PTGIR 💬 | [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 |
24 | KPS-0373, Low dose | - | - | - | - | [1] 18 18 |
25 | KW-6356 Low Dose | - | - | - | - | [1] 6 6 |
26 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | [5] Dapsone Dapsone, Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone | [18] D00385
D00385
,
D00472
,
D00592
,
D00752
,
D00980
,
D00981
,
D00982
,
D00983
,
D00984
,
D00985
,
D01239
,
D01998
,
D02156
,
D03301
,
D05094
,
D05095
,
D05096
,
D06216
| [3] IMPDH1 IMPDH1, IMPDH2, NR3C1 💬 | [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Purine metabolism 💬 | [1] 162 162 |
27 | LiRIS low dose and LiRIS high dose | - | - | - | - | [1] 226 226 |
28 | Low dose | - | - | - | - | [1] 97 97 |
29 | Low dose AFFITOPE® PD03A + Adjuvant | - | - | - | - | [1] 6 6 |
30 | Low dose arm receiving neutral oil and 400 IU/g of Vitamin D every second day | [1] Vitamin D Vitamin D | - | - | - | [1] 13 13 |
31 | Low Dose Aspirin (162 mg/day) | [1] Acetylsalicylic acid Acetylsalicylic acid (Synonym: 81 mg Low Dose Aspirin) | [1] D00109
D00109
| [2] PTGS1 PTGS1, PTGS2 💬 | [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [1] 13 13 |
32 | Low dose BIBF 1120 twice daily | - | - | - | - | [1] 85 85 |
33 | Low dose BIBF1120 once daily | - | - | - | - | [1] 85 85 |
34 | Low Dose Budesonide | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 97 97 |
35 | Low dose budesonide tablet | [1] Budesonide Budesonide | [1] D00246
D00246
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 98 98 |
36 | Low dose cannabis | [1] Medical Cannabis Medical Cannabis | - | - | - | [1] 13 13 |
37 | Low dose levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 6 6 |
38 | Low Dose Mesenchymal Stem Cells (MSCs) | - | - | - | - | [1] 49 49 |
39 | Low Dose MT-1303 | - | - | - | - | [1] 97 97 |
40 | Low dose naltrexone | [1] Naltrexone Naltrexone | [2] D02095
D02095
,
D05113
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬 | [5] Estrogen signaling pathway Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 96 96, 97 |
41 | Low dose of BIIL 284 BS tablets | - | - | - | - | [1] 46 46 |
42 | Low dose ORTD-1 | - | - | - | - | [1] 46 46 |
43 | Low dose prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 84 84 |
44 | Low dose TSO | - | - | - | - | [1] 96 96 |
45 | Low dose vehicle control | - | - | - | - | [1] 46 46 |
46 | Low Dose-VIS649 | - | - | - | - | [1] 66 66 |
47 | LX3305 low dose | - | - | - | - | [1] 46 46 |
48 | M5049 low dose | - | - | - | - | [1] 49 49 |
49 | MEDI7183 low dose | - | - | - | - | [1] 97 97 |
50 | MMX Mesalamine/Mesalazine (Low Dose) | [1] Mesalazine Mesalazine | [1] D00377
D00377
| - | - | [1] 97 97 |
51 | MT-1303 Low dose | - | - | - | - | [1] 49 49 |
52 | MT-7117 Low Dose | - | - | - | - | [1] 254 254 |
53 | MultiStem low dose | [1] MultiStem MultiStem | - | - | - | [1] 97 97 |
54 | Mycophenolate mofetil, low dose steroid | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] D00752
D00752
,
D05094
,
D05095
,
D05096
| [2] IMPDH1 IMPDH1, IMPDH2 💬 | [3] Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism 💬 | [1] 222 222 |
55 | OCU400 Low Dose | - | - | - | - | [1] 90 90 |
56 | Other: Low dose (1 mcg) ACTH stimulation test | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 193 193 |
57 | PF-06649751 low dose (1 mg QD) | [1] Tavapadon Tavapadon | [1] D11431
D11431
| [2] DRD1 DRD1, DRD5 💬 | [10] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, cAMP signaling pathway 💬 | [1] 6 6 |
58 | Prednisone, low dose rituximab | [2] Prednisone Prednisone, Rituximab | [2] D00473
D00473
,
D02994
| [2] MS4A1 MS4A1, NR3C1 💬 | [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 61 61 |
59 | PXT3003 Low dose | - | - | - | - | [1] 10 10 |
60 | Ravicti low dose | [1] Glycerol phenylbutyrate Glycerol phenylbutyrate | [1] D10127
D10127
| - | - | [1] 299 299 |
61 | SA001 Low dose | - | - | - | - | [1] 53 53 |
62 | SEN0014196 (Low Dose) | - | - | - | - | [1] 8 8 |
63 | SHR1459 Low Dose | - | - | - | - | [1] 222 222 |
64 | TAS5315 low dose | - | - | - | - | [1] 46 46 |
65 | Tiotropium bromide-low dose-2.5mcg | [1] Tiotropium Tiotropium | - | - | - | [1] 299 299 |
66 | Ursodeoxycholic acid+Low Dose Glucocorticoid(Methylprednisolone) | [2] Methylprednisolone Methylprednisolone, Ursodeoxycholic acid | [7] D00407
D00407
,
D00734
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [2] NR1H4 NR1H4, NR3C1 💬 | [2] Bile secretion Bile secretion, Neuroactive ligand-receptor interaction 💬 | [1] 93 93 |
67 | YRA-1909 low dose | - | - | - | - | [1] 46 46 |